1.86
                                            Schlusskurs vom Vortag:
              $1.92
            Offen:
              $1.93
            24-Stunden-Volumen:
                112.18K
            Relative Volume:
              0.29
            Marktkapitalisierung:
                $217.34M
            Einnahmen:
              -
            Nettoeinkommen (Verlust:
              $-13.73M
            KGV:
              -14.31
            EPS:
                -0.13
            Netto-Cashflow:
                $-3.92M
            1W Leistung:
              -1.59%
            1M Leistung:
              -5.58%
            6M Leistung:
                +45.31%
            1J Leistung:
              +98.44%
            Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Firmenname
                  
                      Tiziana Life Sciences Ltd
                    
                Sektor
                  Branche
                  Telefon
                  
                      -
                    
                Adresse
                  
                      -
                    
                Vergleichen Sie TLSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                TLSA
                            
                             
                        Tiziana Life Sciences Ltd 
                           | 
                    1.86 | 228.14M | 0 | -13.73M | -3.92M | -0.13 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2020-12-22 | Eingeleitet | B. Riley Securities | Buy | 
| 2018-12-17 | Eingeleitet | Laidlaw | Buy | 
Tiziana Life Sciences Ltd Aktie (TLSA) Neueste Nachrichten
Is Tiziana Life Sciences Ltd stock entering bullish territoryJuly 2025 Spike Watch & Low Volatility Stock Recommendations - newser.com
What technical signals suggest for Tiziana Life Sciences Ltd stockOptions Play & Advanced Swing Trade Entry Plans - newser.com
Analyzing recovery setups for Tiziana Life Sciences Ltd investorsMarket Growth Report & Weekly High Potential Stock Alerts - newser.com
How Tiziana Life Sciences Ltd stock valuations compare to rivalsStop Loss & Accurate Trade Setup Notifications - newser.com
Will Tiziana Life Sciences Ltd stock recover faster than marketJuly 2025 Market Mood & Momentum Based Trading Ideas - newser.com
Is Tiziana Life Sciences Ltd stock a buy before product launchesInsider Selling & Stock Portfolio Risk Management - newser.com
How Tiziana Life Sciences Ltd stock compares to industry benchmarksJuly 2025 Fed Impact & Verified Swing Trading Watchlist - newser.com
Is Tiziana Life Sciences Ltd stock recession proof2025 Investor Takeaways & Safe Investment Capital Preservation Plans - newser.com
Applying big data sentiment scoring on Tiziana Life Sciences LtdRate Cut & Verified Momentum Watchlists - newser.com
Can momentum traders help lift Tiziana Life Sciences LtdMarket Rally & Verified Momentum Stock Watchlist - newser.com
Can Tiziana Life Sciences Ltd stock outperform in 2025 bull marketSell Signal & Technical Analysis for Trade Confirmation - newser.com
How to use a screener to detect Tiziana Life Sciences Ltd breakoutsMarket Activity Summary & Capital Efficiency Focused Strategies - newser.com
Will a bounce in Tiziana Life Sciences Ltd offer an exit2025 Risk Factors & High Win Rate Trade Alerts - newser.com
How to manage a losing position in Tiziana Life Sciences Ltd2025 Bull vs Bear & High Return Trade Opportunity Guides - newser.com
Tiziana Life Sciences: Foralumab's Intranasal Push Is A Good Moonshot (NASDAQ:TLSA) - Seeking Alpha
Published on: 2025-10-31 05:15:32 - newser.com
Reversal indicators forming on Tiziana Life Sciences Ltd stockTrade Volume Report & Capital Efficiency Focused Strategies - newser.com
Has Tiziana Life Sciences Ltd found a price floorWeekly Profit Recap & AI Optimized Trade Strategies - newser.com
Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy - The Manila Times
Tiziana (Nasdaq: TLSA) to present at BIO-Europe on intranasal foralumab for na‑SPMS, MSA - Stock Titan
Tiziana Life Sciences to showcase intranasal foralumab at BIO-Europe 2025 - Proactive financial news
What hedge fund activity signals for Tiziana Life Sciences Ltd stockLong Setup & AI Forecasted Entry/Exit Points - newser.com
How Tiziana Life Sciences Ltd stock trades during market volatilityJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Finanzdaten der Tiziana Life Sciences Ltd-Aktie (TLSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):